Michael Schreck - Feb 14, 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Schreck
Stock symbol
IDXX
Transactions as of
Feb 14, 2024
Transactions value $
-$65,586
Form type
4
Date filed
2/16/2024, 05:58 PM
Previous filing
Jan 5, 2024
Next filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +80 +14.95% $0.00 615 Feb 14, 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +118 +19.19% $0.00 733 Feb 14, 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +170 +23.19% $0.00 903 Feb 14, 2024 Direct
transaction IDXX Common Stock Tax liability -$65.6K -117 -12.96% $560.56 786 Feb 14, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +5.41K $0.00 5.41K Feb 14, 2024 Common Stock 5.41K $560.56 Direct F1
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +178 $0.00 178 Feb 14, 2024 Common Stock 178 $560.56 Direct F2
transaction IDXX Restricted Stock Unit Award $0 +1.2K $0.00 1.2K Feb 14, 2024 Common Stock 1.2K Direct F3
transaction IDXX Restricted Stock Unit Options Exercise $0 -80 -50% $0.00 80 Feb 14, 2024 Common Stock 80 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -118 -33.52% $0.00 234 Feb 14, 2024 Common Stock 118 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -170 -25.07% $0.00 508 Feb 14, 2024 Common Stock 170 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
F2 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
F3 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four equal annual installments beginning on February 14, 2022.
F5 Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four equal annual installments beginning on February 14, 2023.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four equal annual installments beginning on February 14, 2024.